- Carlsson R, Galmiche JP, Dent J, Lundell L, Prison L. Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta-analysis of long-term omeprazole trials. Aliment Pharmacol Ther 1997;11:473-82.
- Robinson M, Lanza F, Avner D, Haber M. Effective maintenance treatment of reflux esophagitis with low-dose lansoprazole. Annals Intern Med 1996, May 15;124(10):859-67.
- Howden CW, Preston JW. Setting the 'gold standards' in the management of gastroesophagea 1 reflux disease. Gastroenterol Today 1996;6(2).
- Thoring M, Hedenstrom H, Eriksson LS. Rapid effect of lansoprazole on intragastric pH: a crossover comparison with omeprazole. Scand J Gastroenterol 1999;34:341-5.
- Lind T, Havelund T, Lundell L, Glise H, Lauritsen K, Pedersen A. On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis: a placebocontrolled randomized trial. Aliment Pharmacol Ther 1999;13: 907-14.
- Talley NJ, Venables TL, Green JBR, Armstrong D, O'Kane KPJ, Giaffer M, et al. Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negativ e GERD: a placebo-controlled trial of on demand therapy for 6 months. Gastroenterology 2000;118:A658.
Scandinavian Journal of Gastroenterology
Volume 37, 2002 - Issue 6